These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 35337163)

  • 1. Cannabidiol on the Path from the Lab to the Cancer Patient: Opportunities and Challenges.
    Olivas-Aguirre M; Torres-López L; Villatoro-Gómez K; Perez-Tapia SM; Pottosin I; Dobrovinskaya O
    Pharmaceuticals (Basel); 2022 Mar; 15(3):. PubMed ID: 35337163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabidiol for Pain Treatment: Focus on Pharmacology and Mechanism of Action.
    Mlost J; Bryk M; Starowicz K
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33238607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Cannabidiol for Improvement of the Quality of Life in Cancer Patients: Potential and Challenges.
    Green R; Khalil R; Mohapatra SS; Mohapatra S
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabis for the Treatment of Epilepsy: an Update.
    Gaston TE; Szaflarski JP
    Curr Neurol Neurosci Rep; 2018 Sep; 18(11):73. PubMed ID: 30194563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuronal and molecular effects of cannabidiol on the mesolimbic dopamine system: Implications for novel schizophrenia treatments.
    Renard J; Norris C; Rushlow W; Laviolette SR
    Neurosci Biobehav Rev; 2017 Apr; 75():157-165. PubMed ID: 28185872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging Therapeutic Potential of Cannabidiol (CBD) in Neurological Disorders: A Comprehensive Review.
    Singh K; Bhushan B; Chanchal DK; Sharma SK; Rani K; Yadav MK; Porwal P; Kumar S; Sharma A; Virmani T; Kumar G; Noman AA
    Behav Neurol; 2023; 2023():8825358. PubMed ID: 37868743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transdermal Delivery of Cannabidiol for the Management of Acute Inflammatory Pain: A Comprehensive Review of the Literature.
    Lefebvre È; Tawil N; Yahia L
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of cannabidiol's inhibitory effect on alpha-glucosidase and its stability in simulated gastric and intestinal fluids.
    Ma H; Li H; Liu C; Seeram NP
    J Cannabis Res; 2021 Jun; 3(1):20. PubMed ID: 34162444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Cannabidiol on Innate Immunity: Experimental Evidence and Clinical Relevance.
    Martini S; Gemma A; Ferrari M; Cosentino M; Marino F
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabidiol Use for Fibromyalgia: Prevalence of Use and Perceptions of Effectiveness in a Large Online Survey.
    Boehnke KF; Gagnier JJ; Matallana L; Williams DA
    J Pain; 2021 May; 22(5):556-566. PubMed ID: 33400996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cannabidiol-loaded Mg-gallate metal-organic framework-based potential therapeutic for glioblastomas.
    Sharma A; Kumar A; Li C; Panwar Hazari P; Mahajan SD; Aalinkeel R; Sharma RK; Swihart MT
    J Mater Chem B; 2021 Mar; 9(10):2505-2514. PubMed ID: 33657198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabidiol's neuroprotective properties and potential treatment of traumatic brain injuries.
    Aychman MM; Goldman DL; Kaplan JS
    Front Neurol; 2023; 14():1087011. PubMed ID: 36816569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway: novel anti-tumor mechanisms of Cannabidiol in breast cancer.
    Elbaz M; Nasser MW; Ravi J; Wani NA; Ahirwar DK; Zhao H; Oghumu S; Satoskar AR; Shilo K; Carson WE; Ganju RK
    Mol Oncol; 2015 Apr; 9(4):906-19. PubMed ID: 25660577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of cannabidiol (CBD) for the treatment of chronic pain.
    Urits I; Gress K; Charipova K; Habib K; Lee D; Lee C; Jung JW; Kassem H; Cornett E; Paladini A; Varrassi G; Kaye AD; Viswanath O
    Best Pract Res Clin Anaesthesiol; 2020 Sep; 34(3):463-477. PubMed ID: 33004159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Potential Clinical Implications and Importance of Drug Interactions Between Anticancer Agents and Cannabidiol in Patients With Cancer.
    Opitz BJ; Ostroff ML; Whitman AC
    J Pharm Pract; 2020 Aug; 33(4):506-512. PubMed ID: 30776990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabidiol as a Potential Treatment for Anxiety and Mood Disorders: Molecular Targets and Epigenetic Insights from Preclinical Research.
    Melas PA; Scherma M; Fratta W; Cifani C; Fadda P
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33668469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of Oxidative Stress and Neuroinflammation by Cannabidiol (CBD): Promising Targets for the Treatment of Alzheimer's Disease.
    Hickey JP; Collins AE; Nelson ML; Chen H; Kalisch BE
    Curr Issues Mol Biol; 2024 May; 46(5):4379-4402. PubMed ID: 38785534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological properties of cannabidiol in the treatment of psychiatric disorders: a critical overview.
    Mandolini GM; Lazzaretti M; Pigoni A; Oldani L; Delvecchio G; Brambilla P
    Epidemiol Psychiatr Sci; 2018 Aug; 27(4):327-335. PubMed ID: 29789034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic literature review of human studies assessing the efficacy of cannabidiol for social anxiety.
    Fliegel DK; Lichenstein SD
    Psychiatry Res Commun; 2022 Dec; 2(4):. PubMed ID: 36875967
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.